{"id":"tp-56704","type":"article-newspaper","title":"Crescent Biopharma Posts $37.7 Million Q3 Loss as R&D Costs Rise","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/56704","datePublished":"2026-11-13T13:35:24.000Z","dateModified":"2026-11-13T13:35:24.000Z","language":"en","abstract":"The net loss widened from $24.607 million a year earlier, while the per-share loss narrowed to $0.90. Crescent had $289.4 million in cash at quarter-end.","section":"Business","references":[]}